药物靶点的发现在药物研发中发挥着至关重要的作用,非标记的药物靶点发现技术因其无需改造药物小分子结构,能更真实反映小分子药物与靶点互作,成为药物靶点发现的新途径。中药(traditional Chinese medicines,TCMs)具有多成分、多靶点...药物靶点的发现在药物研发中发挥着至关重要的作用,非标记的药物靶点发现技术因其无需改造药物小分子结构,能更真实反映小分子药物与靶点互作,成为药物靶点发现的新途径。中药(traditional Chinese medicines,TCMs)具有多成分、多靶点的特性,其作用靶点及机制的研究备受制约,鉴于非标记的药物靶点发现技术在TCMs化学成分靶点发现研究中的应用潜力,本文综述了非标记的药物靶点发现新技术及其在TCMs研究中的应用,为TCMs化学成分靶点的发现提供参考,为促进TCMs现代化的发展提供新思路。展开更多
W026B is a new compound that has a protective effect on cerebral ischemia reperfusion(I-R)injury in mice,while its specific mechanism is still unknown.In this study,proteomics was used to observe the effect of W026B o...W026B is a new compound that has a protective effect on cerebral ischemia reperfusion(I-R)injury in mice,while its specific mechanism is still unknown.In this study,proteomics was used to observe the effect of W026B on protein expression in brain I-R tissue,and to reveal its potential target.A total of 42 significantly altered proteins were identified in both brain I-R model and W026B treatment from 4852 proteins detected by proteomics,and most of these proteins were related to immunity and inflammation,metabolism,neuroprotection as well as cell proliferation and cell structure.Western blotting analysis showed that three out of five selected proteins showed consistent alteration with the proteomics.Regulator of G protein signaling 17(RGS17)was selected for further study,and its knockdown by siRNA RGS17 aggravated brain injury and abolished the protective effect of W026B.W026B could bind with RGS17(KD:6.04×10–6 mol/L).The knockdown of RGS17 aggravated Neuro-2 a cell damage induced by group I metabotropic glutamate receptors(mGluRs)agonist,and abolished the protective effect of W026B.In conclusion,W026B protected brain against I-R injury by affecting diverse proteins.RGS17 might be one of its targets and a potential therapeutic target of brain I-R injury.The upstream receptor of G protein,which was regulated by RGS17 and affected by W026B,might be group I m GluRs.This study provided useful evidence for the further R&D and the potential clinical application of W026B.展开更多
OBJECTIVE: To explore the role of Traditional Chinese Medicine(TCM) in the prevention and treatment of colorectal cancer and identify possible therapeutic targets of TCM to provide clues for the use of TCM for colorec...OBJECTIVE: To explore the role of Traditional Chinese Medicine(TCM) in the prevention and treatment of colorectal cancer and identify possible therapeutic targets of TCM to provide clues for the use of TCM for colorectal cancer prevention and treatment in the clinic and to find novel directions for new drug discovery for colorectal cancer.METHODS: We used Pub Med and Google to search for and collect scientific publications for a full evaluation of current evidence in the literature indicating the potential role of Chinese herbal medicines and their respective ingredients as effective candidatesforcolorectalcancerpreventionandtreatment.RESULTS: We extracted a detailed description of potential therapeutic Chinese herbal medicines and their constituent ingredients that target different mechanisms in colorectal cancer such as gene mutation, dysregulation of signaling pathways, metabolism disorders, and the inflammatory microenvironment, including both conventional and non-conventional approaches.CONCLUSION: TCM may be a promising complementary and alternative therapy for the treatment of colorectal cancer.展开更多
文摘药物靶点的发现在药物研发中发挥着至关重要的作用,非标记的药物靶点发现技术因其无需改造药物小分子结构,能更真实反映小分子药物与靶点互作,成为药物靶点发现的新途径。中药(traditional Chinese medicines,TCMs)具有多成分、多靶点的特性,其作用靶点及机制的研究备受制约,鉴于非标记的药物靶点发现技术在TCMs化学成分靶点发现研究中的应用潜力,本文综述了非标记的药物靶点发现新技术及其在TCMs研究中的应用,为TCMs化学成分靶点的发现提供参考,为促进TCMs现代化的发展提供新思路。
基金National Natural Science Foundation of China(Grant No.81503060,81573333)
文摘W026B is a new compound that has a protective effect on cerebral ischemia reperfusion(I-R)injury in mice,while its specific mechanism is still unknown.In this study,proteomics was used to observe the effect of W026B on protein expression in brain I-R tissue,and to reveal its potential target.A total of 42 significantly altered proteins were identified in both brain I-R model and W026B treatment from 4852 proteins detected by proteomics,and most of these proteins were related to immunity and inflammation,metabolism,neuroprotection as well as cell proliferation and cell structure.Western blotting analysis showed that three out of five selected proteins showed consistent alteration with the proteomics.Regulator of G protein signaling 17(RGS17)was selected for further study,and its knockdown by siRNA RGS17 aggravated brain injury and abolished the protective effect of W026B.W026B could bind with RGS17(KD:6.04×10–6 mol/L).The knockdown of RGS17 aggravated Neuro-2 a cell damage induced by group I metabotropic glutamate receptors(mGluRs)agonist,and abolished the protective effect of W026B.In conclusion,W026B protected brain against I-R injury by affecting diverse proteins.RGS17 might be one of its targets and a potential therapeutic target of brain I-R injury.The upstream receptor of G protein,which was regulated by RGS17 and affected by W026B,might be group I m GluRs.This study provided useful evidence for the further R&D and the potential clinical application of W026B.
基金Supported by National Natural Science Foundation of China(Research for the Mechanism of Fei-Liu-Ping Ointment Regulating Tumor Inflammatory Microenvironment to Prevent Lung Cancer Metastasis,No.81273718)China Postdoctoral Science Foundation(In vitro study on Fei-Liu-Ping ointment preventing lung cancer metastasis caused by inflammatory microenvironment,No.2012T50199)
文摘OBJECTIVE: To explore the role of Traditional Chinese Medicine(TCM) in the prevention and treatment of colorectal cancer and identify possible therapeutic targets of TCM to provide clues for the use of TCM for colorectal cancer prevention and treatment in the clinic and to find novel directions for new drug discovery for colorectal cancer.METHODS: We used Pub Med and Google to search for and collect scientific publications for a full evaluation of current evidence in the literature indicating the potential role of Chinese herbal medicines and their respective ingredients as effective candidatesforcolorectalcancerpreventionandtreatment.RESULTS: We extracted a detailed description of potential therapeutic Chinese herbal medicines and their constituent ingredients that target different mechanisms in colorectal cancer such as gene mutation, dysregulation of signaling pathways, metabolism disorders, and the inflammatory microenvironment, including both conventional and non-conventional approaches.CONCLUSION: TCM may be a promising complementary and alternative therapy for the treatment of colorectal cancer.